Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung Cancer

Author： Luo Ting Zhang Qinrong Lu Qing-Bin

Publisher： MDPI

E-ISSN： 2072-6694|9|6|63-63

ISSN： 2072-6694

Source： Cancers, Vol.9, Iss.6, 2017-06, pp. : 63-63

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J. Anderson N. Bern M. Coco F. Gotthardt S. Oliynyk P. Dow E.

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite

Targeted therapy for non-small-cell lung cancer: past, present and future

By Forde Patrick M Ettinger David S

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 745-758

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in advanced non-small-cell lung cancer

By Di Maio Massimo Gridelli Cesare Grossi Francesco Novello Silvia de Marinis Filippo

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 493-504

Future Medicine

Access to resources Recommend Favorite

Rare mutations in non-small-cell lung cancer

By D’Arcangelo Manolo D’Incecco Armida Cappuzzo Federico

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 699-711

Future Medicine

Access to resources Recommend Favorite

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

By Mortenson Melinda Schlieman Michael Virudachalam Subbulakshmi Bold Richard

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 343-353

Springer Publishing Company

Access to resources Recommend Favorite